Category Matches
- 0.1 mg
- 0.5 mg
- 1 g
- 1 kg
- 1 kit
- 1 L
- 1 mg
- 1 ml
- 1 MU
- 1 Plate
- 1 µg
- 10 g
- 10 mg
- 10 ml
- 10 µg
- 100 g
- 100 mg
- 100 mh
- 100 ml
- 100 Tests
- 100 µg
- 100-200 Tests
- 1000 g
- 100g
- 11β-HSD Inhibitor
- 125 mg
- 125 Tests
- 1mg
- 2-Deoxy-D-Glucose
- 2-deoxy-D-glucose
- 2-DG
- 20 g
- 20 mg
- 20 Tests
- 200 Tests
- 200 µg
- 25-250 Tests
- 25-50 Tests
- 250 g
- 250 mg
- 250 ml
- 250 Tests
- 250 µg
- 250mg
- 30S
- 400 Tests
- 5 x 100 µg
- 5 x 50 µg
- 5-a-reductase Inhibitors
- 5-bromo-2'-deoxyuridine
- 5-HT1 Receptors - Analgesics
- 5-HT1 Receptors - Antidepressant
- 5-HT1 Receptors - Antipsychotic
- 5-HT1 Receptors - Anxiolytic
- 5-HT1 Receptors - Cognition Enhancing
- 5-HT1 Receptors - Hypnotics
- 5-HT1 Receptors - Sedatives
- 5-HT2 Receptors - Antidepressant
- 5-HT2 Receptors - Neurodegenerative Diseases
- 5-HT2 Receptors - Sedatives
- 5-HT3 Receptors - Antidepressant
- 5-HT3 Receptors - Sedatives
- 5-HT5 Receptors - Antidepressant
- 5-HT5 Receptors - Neurodegenerative Diseases
- 5-HT5 Receptors - Sedatives
- 5-HT6 Receptors - Antidepressant
- 5-HT6 Receptors - Neurodegenerative Diseases
- 5-HT6 Receptors - Sedatives
- 5-HT7 Receptors - Antidepressant
- 5-HT7 Receptors - Sedatives
- 5-α-Reductase Inhibitors
- 50 g
- 50 mg
- 50 ml
- 50 Tests
- 50 U
- 50 µg
- 50-100 Tests
- 500 g
- 500 KU
- 500 mg
- 500 mL
- 500 mt
- 500 Tests
- 500 µg
- 500 µl
- 500µg
- 50S
- 5x50 µg
- 6-hydroxydopamine
- 6-OHDA
- a-Glucosidase Inhibitors
- Acetic Acid Derivatives
- AChE - Neurodegenerative Diseases
- ACP-196
- ACP196
- Adenosine
- Adenosine Antagonists (Xanthines)
- Adenosine Receptors - Analgesics
- Adenosine Receptors - Antiepileptics and Anticonvulsants
- Adenosine Receptors - Anxiolytic
- Adenosine Receptors - Cognition Enhancing
- Adenosine Receptors - Neurodegenerative Diseases
- Adenosine Receptors - Sedatives
- Adenosine/Adenine
- Adrenal Hormones and Modulators
- Adrenergic Agonists
- Adrenergic Receptors - Analgesics
- Adrenergic Receptors - Anesthetic
- Adrenergic Receptors - Antidepressant
- Adrenergic Receptors - Antiepileptics and Anticonvulsants
- Adrenergic Receptors - Antipsychotic
- Adrenergic Receptors - Anxiolytic
- Adrenergic Receptors - Cognition Enhancing
- Adrenergic Receptors - Hypnotics
- Adrenergic Receptors - Neurodegenerative Diseases
- Adrenergic Receptors - Sedatives
- adu-s100
- adus100
- Aldosterone and ENaC Antagonists (K+ Sparing diuretics)
- Aldosterone Antagonists
- Aldosterone Antagonists - Antihypertensive
- alkaloid
- alkaloids
- ally disulfide
- alvocidib
- Alzheimer's Disease
- Alzheimer's Disease
- Amino acid Neurotransmitters
- aminoglycosides
- Aminonucleosides
- AMPA - Neurodegenerative Diseases
- AMPA - Sedatives
- Amphibian peptides and Hormones
- AMPK - Neurodegenerative Diseases
- Analgesics and Antinociceptives
- Androgen Receptor Modulators
- Androgen Synthesis Inhibitors
- Androgens
- andrographolide
- Anti-glucocorticoids
- Anti-mineralocorticoids
- Anti-ulceratives and Antacids
- Antiandrogens
- Antidepressant
- Antidiabetic
- Antiepileptics and Anticonvulsants
- Antihistamines - Therapies for Respiratory Diseases and Allergy Management
- Antihyperlipidemics
- Antimicrobial - Peptides
- Antimicrobial Peptides - Microbiology
- Antimicrobial Peptides - Natural Products
- Antimicrobial Peptides - Others
- Antioxidant
- Antiplatelet Compounds
- Apicidin
- Appetite Modulators
- Arthropod peptides and Hormones
- AT-7519
- AT7519
- AZ-5104
- AZ5104
- AZD-1152
- AZD-1152-HQPA
- AZD-1208
- AZD-5363
- AZD-8186
- AZD-9291
- B02
- BACE1
- BAY1816032
- BAY80-6946
- BChE - Neurodegenerative Diseases
- Bedaquiline
- Beta Blockers - Anti-anginal
- Beta-Adrenergic Agonists
- Beta-Adrenergic Receptor Antagonists
- beta-zearalanol
- beta-zearalenol
- Biguanides
- BIX01294
- BMS-754807
- Bone Disease Treatments
- BRD
- BUB1
- budesonide
- BYL719
- Ca2+ Channel Blockers - Vasodilatory
- Ca2+ Channels - Antidepressant
- Ca2+ Channels - Antiepileptics and Anticonvulsants
- Ca2+ Channels - Sedatives
- Ca2+ Ion Channels - Neurodegenerative Diseases
- Ca2+-sensing Receptors - Neurodegenerative Diseases
- Calcitriol (VDR) Agonists
- Cannabinoid Receptors - Analgesics
- Cannabinoid Receptors - Antidepressant
- Cannabinoid Receptors - Anxiolytic
- Cannabinoid Receptors - Sedatives
- Carcinogens and Mutagens
- Cardiomodulatory
- Cardioprotective
- Cardiovascular
- Carotenoids
- CDK
- ceftazidime
- Cell Membrane Modifiers
- CEP-28122
- chemicals for COVID-19 research
- CHIR99021
- Chk1/2
- chondroitin
- Class II (Beta Blocker)
- compound c
- Compounds targeting DNA synthesis and repair
- COMT - Neurodegenerative Diseases
- Corticosteroids and Modulators
- COVID
- COVID
- COVID-19
- covid-19
- COVID-19 chemicals
- COVID-19 compounds
- COX-1 - Analgesics
- CPI-203
- CYP17A1 Inhibitors
- Cytidine
- Cytidine/Cytosine
- D-amino Acid Oxidase - Analgesics
- D-amino Acid Oxidase - Antidepressant
- D-amino Acid Oxidase - Antipsychotic
- D-amino Acid Oxidase - Sedatives
- D1 Receptors - Analgesics
- D1 Receptors - Anesthetic
- D1 Receptors - Antidepressant
- D1 Receptors - Antipsychotic
- D1 Receptors - Anxiolytic
- D1 Receptors - Cognition Enhancing
- D1 Receptors - Neurodegenerative Diseases
- D1 Receptors - Sedatives
- D2 Receptor Antagonists
- D2 Receptors - Analgesics
- D2 Receptors - Anesthetic
- D2 Receptors - Antidepressant
- D2 Receptors - Antipsychotic
- D2 Receptors - Anxiolytic
- D2 Receptors - Cognition Enhancing
- D2 Receptors - Neurodegenerative Diseases
- D2 Receptors - Sedatives
- D3 Receptors - Analgesics
- D3 Receptors - Antidepressant
- D3 Receptors - Antipsychotic
- D3 Receptors - Anxiolytic
- D3 Receptors - Cognition Enhancing
- D3 Receptors - Neurodegenerative Diseases
- D3 Receptors - Sedatives
- D4 Receptors - Analgesics
- D4 Receptors - Antidepressant
- D4 Receptors - Antipsychotic
- D4 Receptors - Anxiolytic
- D4 Receptors - Cognition Enhancing
- D4 Receptors - Neurodegenerative Diseases
- D4 Receptors - Sedatives
- D5 Receptors - Antidepressant
- D5 Receptors - Antipsychotic
- D5 Receptors - Anxiolytic
- D5 Receptors - Cognition Enhancing
- D5 Receptors - Sedatives
- DA Receptor Signaling - Analgesics
- DA Receptor Signaling - Anesthetic
- DA Receptor Signaling - Antidepressant
- DA Receptor Signaling - Antipsychotic
- DA Receptor Signaling - Anxiolytic
- DA Receptor Signaling - Cognition Enhancing
- DA Receptor Signaling - Neurodegenerative Diseases
- DA Receptor Signaling - Sedatives
- Dabrafenib
- dabrafenib
- daclatasvir
- dactylosporangium
- darunavir
- DAT - Antidepressant
- DAT - Anxiolytic
- DAT - Neurodegenerative Diseases
- DAT - Sedatives
- DATS
- Daunorubicin
- deferiprone
- deoxyalliin
- deoxynivalenol
- destruxin A
- destruxin B
- dexamethasone
- dexamethasone
- dextromethorphan
- diallyl disulfide
- diallyl sulfide
- diallyl tetrasulfide
- diallyl trisulfide
- diazene oxide
- diclofenac
- Dietary Supplements
- difenoconazole
- Differentiation
- dihydroartemisinin
- Dihydrofolate Reductase
- Dihydrofolate Reductase Inhibitors
- dinaciclib
- diosmin
- dipropyl disulfide
- dipropyl sulfide
- Disinfectants
- Diuretics
- DNA and RNA Synthesis Inhibitors
- DNA Crosslinking and Alkylating Agents
- DNA Methyltransferase
- DNA Polymerase
- DNA Strand Break-Inducing Agents
- DNA-PK
- docetaxel
- docetaxel impurity B
- dopamine agonists
- Dopamine Receptor Inhibitors
- dopaminergic neurons
- dorsomorphin
- DOT1L Histone Methyltransferase
- doxorubicin
- DPP-4 Inhibitors
- dye
- dysoxylum
- Eicosanoid Inhibitors
- eidd-1931
- EIDD-2801
- EIDD2801
- eIF2B - Neurodegenerative Diseases
- Endocrine Signaling and Immunology
- Endothelin Receptor Antagonists
- Epigenetic Modifiers
- Essential vitamins and nutrients
- etoposide
- exclude-from-catalog
- exclude-from-search
- Fast Skeletal Muscle Troponin Complex - Neurodegenerative Diseases
- featured
- fexofenadine
- flavonoid
- Flavonoids
- folic acid
- Furans - Other nucleic acid inhibitors
- GABA - Antidepressant
- GABA - Antiepileptics and Anticonvulsants
- GABA - Neurodegenerative Diseases
- GABA - Sedatives
- Gamma Secretase - Neurodegenerative Diseases
- Gastric Inhibitory Peptide
- Gastrin-releasing Peptide
- Gastrointestinal Motility Modulators
- GBR-12935
- GDC-0032
- GDC-0941
- GDC-0973
- GDC-0980
- Ginkgolides and other Ginkgo-related Compounds
- ginsenoside
- Ginsenosides and Other Ginseng-related Compounds
- glimepiride
- glimepiride
- GLP-1 Agonists
- Glucocorticoids
- Glucocorticoids - Other Therapies
- glycopeptides
- Glycyrrhetinic Acid
- Glycyrrhizic Acid
- grouped
- guanine nucleotide exchange factor
- GW-5074
- Haloperidol
- HDAC inhibitor
- hesperidin
- HEXIM1
- HIF-1
- Histamine Receptors - Antidepressant
- Histamine Receptors - Neurodegenerative Diseases
- Histamine Receptors - Sedatives
- Histone Deacetylase
- HMG-CoA Reductase Inhibitors (Statins)
- Hormone Receptor Modulators
- HSP70
- HSP90
- hydrocortisone
- hydrocortisone
- hydroxychloroquine
- hypoerphosphorylated tau
- ifenprodil
- IGF-1R
- imidazole
- Imidazoles
- Imidazoline Receptors - Analgesics
- Imidazoline Receptors - Antipsychotic
- Imidazoline Receptors - Cognition Enhancing
- Imidazoline Receptors - Neurodegenerative Diseases
- Imidazoline Receptors - Sedatives
- Immunomodulatory
- IMPDH
- indinavir
- indole
- Indoleamine 2,3-dioxygenase
- Indomethacin
- Ion channels - Antidepressant
- Ion Channels - Antiepileptics and Anticonvulsants
- Ion Channels - Neurodegenerative Diseases
- Ion Channels - Sedatives
- Isothiocyanate
- JQ-1
- JQ-1
- K+ Channels - Antidepressant
- K+ Channels - Antiepileptics and Anticonvulsants
- K+ Channels - Sedatives
- K+ Ion Channels - Neurodegenerative Diseases
- KNL1
- Kynurenic Acid
- Kynurenine 3-hydroxylase - Neurodegenerative Diseases
- ledipasvir
- lincosamides
- Linezolid
- loratadine
- LOXO-195
- loxo195
- LRRK2 - Neurodegenerative Diseases
- LY-2606368
- LY2606368
- mAChR - Antidepressant
- mAChR - Neurodegenerative Diseases
- mAChR - Sedatives
- macrolides - 50S
- Macrolides - Anti-parasitic
- Madagascar periwinkle
- MAO - Antidepressant
- MAO - Antiepileptics and Anticonvulsants
- MAO - Neurodegenerative Diseases
- MAO - Sedatives
- MDM2
- Meglitinides
- Melatonin Receptors - Antidepressant
- Melatonin Receptors - Neurodegenerative Diseases
- Melatonin Receptors - Sedatives
- Metabolic and GI Pathology
- methylprednisolone
- metronidazole
- mGlu - Sedatives
- mGluR - Antiepileptics and Anticonvulsants
- Microtubule Polymerization/Depolymerization Inhibitors
- Midostaurin
- Mineralocorticoids
- Mycophenolic Acid
- mycophenolic acid
- N-Arylanthranilic acid Derivatives (Fenamates)
- N4-hydroxycytidine
- Na+ Channels - Antidepressant
- Na+ Channels - Antiepileptics and Anticonvulsants
- Na+ Channels - Sedatives
- Na+ Ion Channels - Neurodegenerative Diseases
- nAChR - Antidepressant
- nAChR - Antiepileptics and Anticonvulsants
- nAChR - Neurodegenerative Diseases
- nAChR - Sedatives
- nanostructure lipid carrier
- Natural Products
- NCCT Inhibitors (Thiazide/Thiazide-like diuretics)
- NET - Antidepressant
- NET - Neurodegenerative Diseases
- NET - Sedatives
- Neuraminidase Inhibitors
- Neurodegenerative Diseases
- Neuromodulatory
- New Products
- Nitrogen Mustards
- Nitroimidazoles - Anti-parasitic
- Nitroimidazoles - Antibacterial
- Nitrovasodilators
- NK - Neurodegenerative Diseases
- NKCC1 Inhibitors (Loop Diuretics)
- NMDA - Analgesics
- NMDA - Anesthetic
- NMDA - Antidepressant
- NMDA - Antiepileptics and Anticonvulsants
- NMDA - Antipsychotic
- NMDA - Anxiolytic
- NMDA - Cognition Enhancing
- NMDA - Sedatives
- NMDA Receptors - Neurodegenerative Diseases
- NSAID
- NSAIDs
- NSAIDs: COX-1 Inhibitors
- NSAIDs: COX-2 Inhibitors
- nu2058
- Nucleoside and Nucleotide Analogs
- Nucleoside/Nucleotide analogs
- odontoblast
- OHDA
- Okadaic Acid
- Okadaic Acid Ammonium
- Okadiac Acid Sodium
- olopatadine
- Opioid Peptide Agonists
- Opioid Receptor Agonists
- Opioid Receptor Antagonists
- Opioid Receptors - Analgesics
- Opioid Receptors - Anesthetic
- Opioid Receptors - Antidepressant
- Opioid Receptors - Antiepileptics and Anticonvulsants
- Opioid Receptors - Anxiolytic
- Opioid Receptors - Cognition Enhancing
- Opioid Receptors - Neurodegenerative Diseases
- Opioid Receptors - Sedatives
- Orexin Receptors - Sedatives
- Other Compounds
- Other DA Signaling - Analgesics
- Other DA Signaling - Anesthetic
- Other DA Signaling - Antidepressant
- Other DA Signaling - Antipsychotic
- Other DA Signaling - Anxiolytic
- Other DA Signaling - Cognition Enhancing
- Other DA Signaling - Neurodegenerative Diseases
- Other DA Signaling - Sedatives
- Other Diuretics
- Other Hormones and Modulators
- Other Ion Channels - Antidepressant
- Other Ion Channels - Antiepileptics and Anticonvulsants
- Other Ion Channels - Sedatives
- Other Lipid-lowering Compounds
- Other NSAID
- Other Nucleic Acid Inhibitors
- Other Products
- Others - Antidiabetic
- Others - Cell Membrane Modifiers
- Others - Other nucleic acid inhibitors
- OTX-015
- oxazolidinone
- oxazolidinone
- oxidopamine
- p110
- p110alpha
- P2Y12
- Pancreatic Polypeptide
- Parathyroid Hormone Agonists
- Parkinson's Disease
- parthenolide
- PDE
- PDGFR
- PDK1
- pemetrexed
- Peptide Neurotransmitters
- peptide YY
- Peptides
- Pesticides
- Pevonedistat
- PF-07321332
- Pharmaceutical Impurities and Derivatives
- Pharmaceutical Impurities and Derivatives
- Pim-1
- Pim1
- PKC412
- Platinum-based Agents
- polysulfide
- prednisolone
- prednisone
- prednisone acetate
- Prolactin-releasing Peptide Agonists
- Prolyl Oligopeptidase - Neurodegenerative Diseases
- Propionic Acid Derivatives
- Prostaglandin D Synthase Inhibitors
- Prostaglandin Synthetase - Analgesics
- Purine derivatives
- Pyrazolidines
- Rac1
- RAD51
- rancidity
- rated-1
- rated-2
- rated-3
- rated-4
- rated-5
- remdesivir
- Ribonucleotide Reductase
- RN-1734
- ROS1
- SB-203580
- SB-431542
- Sedative
- Sedatives and Hypnotics
- ser910
- Serotonin Receptors - Antidepressant
- Serotonin Receptors - Neurodegenerative Diseases
- Serotonin Receptors - Sedatives
- SERT - Antidepressant
- SERT - Neurodegenerative Diseases
- SERT - Sedatives
- sesterterpenoid
- Sex steroids and Modulators
- Sigma Receptors - Antidepressant
- Sigma Receptors - Antiepileptics and Anticonvulsants
- Sigma Receptors - Neurodegenerative Diseases
- Sigma Receptors - Sedatives
- SIRT - Neurodegenerative Diseases
- SNS-032
- Stem Cell Modulators
- Steroids Hormones and Modulators
- sting ligand
- su5402
- su9516
- Sulfonamides
- Sutezolid
- T315i
- TAAR - Sedatives
- TAK-931
- tetracyclines - 30S
- Tetrahydropyrimidines
- tetrahydroquinoline
- tetrandrine
- Therapies for Respiratory Diseases and Allergy Management
- thiazolidinedione
- thiocyanate
- thioguanine
- thiolutin
- Thioredoxin Reductase
- thioridazine
- Thymidine
- Thymidine/Thymine
- Thymidylate Synthase
- Thyroid Hormone Agonists
- Thyroid Hormones and Modulators
- togaviridae
- Transcription Factor Modifiers
- triterpenoid
- Trk Receptors - Neurodegenerative Diseases
- TRP Channels - Antidepressant
- TRP Channels - Antiepileptics and Anticonvulsants
- TRP Channels - Neurodegenerative Diseases
- TRP Channels - Sedatives
- UNC0064-12
- Uncategorized
- Uridine
- Uridine/Uracil
- USP40 Taxol Impurities - Cell Fermentation
- USP40 Taxol Impurities - Isolated
- USP40 Taxol Impurities - Semisynthetic
- V600E
- vadimezan
- Valproic acid
- vanilloid
- Vasodilatory
- VE821
- Verdinexor
- Vinca Alkaloids
- vindoline
- Viral Fusion and Entry Inhibitors
- wc_update_product_lookup_tables
- Website Updates
- woocommerce-db-updates
- α1-adrenergic Receptor Antagonists - Antihypertensive
- α1-adrenergic Receptor Antagonists - Vasodilatory
- α2-adrenergic Receptor Agonists
- β-Glucan Synthase Inhibitors (echinocandins)
Product Matches
Product ID
Name
Description
Purity
- Impact of 2-DG on Triple-Negative Breast CancersTriple-negative breast cancers present a difficult problem. Most existing therap...
- T28331-Thio-β-D-glucose Tetraacetate
Imaging agent; Maillard reaction inhibitor.
≥98% - Sulforaphane Reduces Hepatic Glucose Production in Cell Cultures and Improves Glucose Tolerance in RodentsType 2 diabetes is a chronic condition in which the body resists the effects of ...
- D18592-Deoxy-D-glucose
Glucose metabolism inhibitor, N-linked glycosylation inhibitor.
≥99% - C2943Chlorogenic Acid (from Eucommia)
Polyphenol derivative of caffeic acid found in Eucommia bark; DNMT and G6P tr...
≥98% - AS112Grape Skin Standards Kit
Polydatin, Dihydroresveratrol, Resveratrol, Emodin
- AS111Berry Flavonoid Standards Kit
6 flavonoids
- AS110Red Clover Standards Kit
6 flavonoids
- P2445GLa Peptide
Antimicrobial peptide found in amphibians.
≥98% - C2801Chaetoglobosin A
Cytotoxic and antifungal activities.
≥99% - AS109Soy Isoflavone Standards Kit
6 isoflavones
- M0273Mastoparan 8
Antimicrobial peptide found in bee and wasp venom; Gi/o GPCR agonist.
≥95% - C1609Cecropin B
Antimicrobial peptide found in Hyalophora cecropia and Bombyx mori.
≥95% - M0272Mastoparan 7
Antimicrobial peptide found in bee and wasp venom; Gi/o GPCR agonist, PLA2 ac...
≥95% - AS108Kudzu Flavonoid Standards Kit
6 flavonoids
- B0108Bactenecin
Cathelicidin derivative, antimicrobial peptide, alters bacterial membrane per...
≥95% - M1744Melittin
Antimicrobial peptide found in Apis mellifera.
≥95% - AS107Caffeic Acid Esters Standards Kit
9 caffeic acid compounds
- M0172Mastoparan
Antimicrobial peptide found in Vespula lewisii, mast cell degranulation stimu...
≥95% - AS106Magnolia Standards Kit
Honokiol, Magnolol